ImageneBio IMA
NASDAQ IMA
$5.51 -0.10 (-1.78%)
At close: Aug 21, 2026 · 4:00 PM EDT

ImageneBio (IMA) Return on Assets Growth (1y) (2022 - 2025)

ImageneBio (IMA) Return on Assets Growth (1y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 ImageneBio 47.79 Mn -87.56 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 6.00
Mar 31, 2024 19.00
Dec 31, 2023 17.00
Sep 30, 2023 16.00
Jun 30, 2023 3.00
Mar 31, 2023 -19.00
Dec 31, 2022 -17.00
Sep 30, 2022 -15.00
Jun 30, 2022 -9.00
Mar 31, 2022 0.00